bioAffinity Technologies, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $6.4M | $1.1M | $2.8M | $11.4M | $1.4M |
| Accounts Receivable | — | — | — | — | — |
| Inventory | $53.5K | $27.6K | $18.5K | $5.5K | — |
| Total Current Assets | $7.6M | $2.7M | $4.0M | $12.0M | $1.4M |
| Property, Plant & Equipment | $265.6K | $375.4K | $458.6K | $214.4K | $4.6K |
| Goodwill | $1.4M | $1.4M | $1.4M | — | — |
| Intangible Assets (Excl. Goodwill) | $716.8K | $775.1K | $833.5K | — | — |
| Total Assets | $11.0M | $6.5M | $8.2M | $12.2M | $1.5M |
| Liabilities | |||||
| Accounts Payable | $761.9K | $987.3K | $604.8K | $345.0K | $230.4K |
| Total Current Liabilities | $2.9M | $3.1M | $2.2M | $1.1M | $13.0M |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $3.7M | $3.9M | $3.4M | $1.1M | $13.2M |
| Stockholders' Equity | |||||
| Retained Earnings | $-68.6M | $-53.6M | $-44.6M | $-36.7M | $-28.5M |
| Total Stockholders' Equity | $7.3M | $2.6M | $4.9M | $11.0M | $-15.8M |